Peri-implantitis Implantoplasty Treatment

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age20+
SponsorUniversity of Oslo

About this trial

This double arm, split-mouth, single centre, controlled, randomised clinical study is designed to examine the effect of implantoplasty in treatment of peri-implantitis.

Peri-implantitis will be treated with open flap debridement, with or without implantoplasty.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Peri-implantitis (according to 2018 criteria) on minimum 2 implants of similar surface and defect type

Competent to give consent

Exposed, modified implant surface with loss >2mm

Disqualifiers

Previous radiotherapy to the jaws, current use of chemotherapy, systemic long-term corticosteroid treatment

Present or past use of bisphosphonate treatment • Pregnant or nursing subjects

Patients classified as > class II according to ASA classification

Implant unavailable for implantoplasty treatment

Trial design

Design model

Parallel

Treatments tested in this trial

  • Implantoplasty

    Procedure/Surgery

    Implantoplasty is the mechanical smoothening of rough titanium implants as part of the surgical treatment of peri-implantitis. Treatment is thought to facilitate self-performed oral hygiene.

  • Open flap debridement alone

    Procedure/Surgery

    Open flap debridement alone

Treatment groups

35 Participants
are divided into 2 treatment groups
Group A: Peri-implantitis treatment with implantoplastyExperimental treatment 2 interventions
Group B: Peri-implantitis treatment without implantoplastyActive comparator 2 interventions

Trial outcomes

Primary outcomes

1

Bleeding on probing

Measured with a periodontal probe

Time frame
12 months after treatment
2

Bleeding on probing

Measured with a periodontal probe

Time frame
24 months after treatment

Secondary outcomes

1

Suppuration

Visible suppuration upon probing the implant with a periodontal probe

Time frame
12 months after treatment
2

Suppuration

Visible suppuration upon probing the implant with a periodontal probe

Time frame
24 months after treatment
3

Pocket probing depth

Measured with a periodontal probe

Time frame
12 months after treatment
4

Pocket probing depth

Measured with a periodontal probe

Time frame
24 months after treatment

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.